According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...

The global smart insulin pens market, currently estimated at US$ 3,927.3 million in 2023, is projected to exhibit robust ...

Switzerland-based CeQur has completed a $120m equity financing round to support the ongoing commercialisation efforts for its ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a recently-approved Smart Button device that stores and transfers insulin dose-related data from the pen ...

CeQur announced today that it closed a $120 million financing round to support its wearable insulin delivery technology.

Veterinary toxicologists are warning clients about the dangers of accidental exposure to semaglutide weight loss medications ...

Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support.